vimarsana.com

Latest Breaking News On - Delix therapeutics the company - Page 1 : vimarsana.com

Pioneering Delix Therapeutics Study Published in Science Elucidates the Mechanism of Psychedelic-Induced Neuroplasticity

/PRNewswire/ Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying, neuroplasticity-promoting therapeutics for.

United statesMark rusAbby bergerDavide olsonUniversity of california davisStrategic communicationsDelix therapeutics the companyInstitute for psychedelicsDelix co founderChief innovation officer davidCalifornia davisCell reportsMolecular psychiatryEngineering new topFierce biotechDelix therapeutics

Delix Therapeutics Partners With Cellectricon, Expressive Neuroscience and Expands Science Team To Accelerate Drug Discovery and Translatability

/PRNewswire/ Delix Therapeutics (the "Company"), a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and.

United statesSan diegoAlison mungenastBrigitte robertsonMark rusKurt rasmussenAbby bergerDavide olsonEliseo salinasHealthcare businesswomen associationStrategic communicationsDelix therapeutics the companySociety for neurosciencePioneering neuroscience companyFirst gen psychedelicsAdvance psychoplastogens

Delix Therapeutics Expands World-Class Team with First Head of R&D

/PRNewswire/ Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological.

United statesBrigitte robertsonMark rusKurt rasmussenAbby bergerEliseo salinasElan pharmaceuticalsDelix therapeutics the companyPioneering neuroscience companyDevelopment at wyethStrategic communicationsAcadia pharmaceuticalsEliseo salinas as head of research developmentHead of developmentExecutive eliseo salinasJoins pioneering neuroscience

Nature Biotechnology Selects Delix Therapeutics as a Leading Biotech Start-Up

/PRNewswire/ Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological.

United statesKorro bioMark rusAbby bergerDavide olsonSonoma biotherapeuticsUniversity of californiaStrategic communicationsDelix therapeutics the companyNature biotechnologyChief innovationProfessor olsonSana biotechnologyGraphite bioFierce biotechCell reports

Delix Therapeutics Closes $30 Million Convertible Note Financing, Enters $10 Million Strategic Credit Facility Option in Partnership with Comerica Bank

/PRNewswire/ Delix Therapeutics (the "Company"), a neuroscience company developing novel disease-modifying therapeutics for psychiatric and neurological.

United statesBryan kanaMark rusLee eustisAbby bergerDelix therapeutics the companyLife sciences divisionComerica bankComerica technology life scienceStrategic communicationsComerica incorporatedComerica bank technologyComerica bank technology life sciencesRetail bankDelix therapeuticsStrategic credit facility

vimarsana © 2020. All Rights Reserved.